Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Octave Life Sciences

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$69M
Portfolio companies 2
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Health Care
Summary

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Neuraly.

The typical case for the fund is to invest in rounds with 7 participants. The meaningful sponsors for the fund in investment in the same round are Smilegate Investment, Magna Investment, LB Investment.

The high activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Octave Life Sciences:
Typical Co-investors
Octave Life Sciences is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Octave Life Sciences:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Apple Tree Partners New York, New York, United States
Brain Power China, Guangdong, Shenzhen
Broadband Venture Partners Dallas, Texas, United States
Cadence Bancorp Houston, Texas, United States
CHANEL France, Ile-de-France, Neuilly-sur-seine
Changying Technology China, Guangdong Province, Maoming City
City National Bank California, Los Angeles, United States
CorLyst, LLC Ellicott City, Maryland, United States
CRYSTAL VENTURES -
IDFC Mutual Fund India, Maharashtra, Mumbai
Kaplan Florida, Fort Lauderdale, United States
Logitech Investments -
MCB Salt -
Mendes -
Ministry of Business, Innovation and Employment New Zealand, Wellington, Wellington
Miteno Beijing, Beijing, China
Naos -
WERU Investment Chiyoda, Japan
Youguang Network China, Shanghai, Xuhui

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

D&D Pharmatech

Pharmaceutical
$137M14 Aug 2019 Seongnam-si, Gyeonggi-do, South Korea

Neuraly

Biotechnology
Health Care
$36M18 Jul 2018 Maryland, United States

D&D Pharmatech

Pharmaceutical
$36M01 Jan 2018 Seongnam-si

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Octave Life Sciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 69M
Peak activity year 2018
Lead investments 1
Follow on index 0.33
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

D&D Pharmatech

Pharmaceutical
$137M14 Aug 2019 Seongnam-si, Gyeonggi-do, South Korea

Neuraly

Biotechnology
Health Care
$36M18 Jul 2018 Maryland, United States

D&D Pharmatech

Pharmaceutical
$36M01 Jan 2018 Seongnam-si
Crunchbase icon

Content report

The following text will be sent to our editors: